← Back to 5-Amino-1MQ product page
Reversal of Diet-Induced Obesity in Mouse Models Through NNMT Inhibition
A landmark 2018 study published in Biochemical Pharmacology demonstrated that selective NNMT inhibitors, including 5-Amino-1MQ, reverse high-fat diet-induced obesity in mice. The researchers placed mice on a 60% high-fat diet to establish diet-induced obesity, then administered 5-Amino-1MQ and evaluated its effects on body weight, fat mass, adipocyte size, and metabolic parameters over the treatment period.
The results showed that 5-Amino-1MQ treatment reduced body weight, white adipose tissue mass, total cholesterol, and adipocyte size in obese mice without affecting food intake. In vitro studies confirmed that treatment of 3T3-L1 pre-adipocytes with 10 μM 5-Amino-1MQ did not impact cell viability, establishing that the compound’s anti-adipogenic effects are not due to cytotoxicity. The study demonstrated that NNMT inhibition increases intracellular NAD+ and SAM levels, enhancing cellular energy metabolism and reducing lipid accumulation.
Citation: Neelakantan H, Vance V, Wetzel MD, et al. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. Biochemical Pharmacology. 2018;147:141-152. doi:10.1016/j.bcp.2017.11.007. PubMed PMID: 29155147
NNMT as a Metabolic Regulator: Roles in Obesity and Type 2 Diabetes
A 2021 comprehensive review published in BioMed Research International examined the roles of NNMT in obesity and type 2 diabetes (T2D) research, with detailed discussion of 5-Amino-1MQ as a pharmacological tool for probing NNMT function. The authors catalogued evidence that NNMT expression is upregulated in adipose tissue during obesity and that this upregulation contributes to metabolic dysfunction through depletion of NAD+ and SAM pools.
The review documented that 5-Amino-1MQ treatment in diet-induced obese mice reversed metabolic dysfunction markers associated with obesity, including insulin resistance and dyslipidemia. The authors discussed the mechanistic link between NNMT activity and cellular energy metabolism, noting that NNMT inhibition by 5-Amino-1MQ increases the NAD+/NADH ratio, thereby enhancing sirtuin activity and mitochondrial function. This established a molecular framework for understanding how NNMT inhibition produces its observed anti-obesity effects.
Citation: Liu X, Zhang Y, Chu X, et al. Roles of Nicotinamide N-Methyltransferase in Obesity and Type 2 Diabetes. BioMed Research International. 2021;2021:9924314. doi:10.1155/2021/9924314. PubMed PMID: 34368365
NNMT Inhibition Combined with Calorie Reduction: Microbiome Effects
A 2022 study published in Scientific Reports investigated how NNMT inhibition with 5-Amino-1MQ (5A-1MQ) combined with reduced calorie diet affects the gut microbiome composition in diet-induced obese mice. After establishing obesity via high-fat diet for 12 weeks, mice were randomized to Western diet or lean diet with or without 5A-1MQ treatment for approximately 7 weeks before cecal sample collection and microbiome analysis.
The study found that diet and 5A-1MQ treatment status substantially altered body weight, fat mass, and gut microbiome composition. The combination of calorie reduction with NNMT inhibition established a distinct microbiome profile compared to either intervention alone. The researchers documented shifts in bacterial phyla ratios and identified specific microbial taxa that were differentially abundant in the treatment groups, suggesting a potential gut microbiome-mediated component of 5-Amino-1MQ’s metabolic effects.
Citation: Neelakantan H, Brightwell CR, Graber TG, et al. Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice. Scientific Reports. 2022;12(1):629. doi:10.1038/s41598-021-04714-6. PubMed PMID: 35013352
NNMT in Cardiovascular Disease: Emerging Research Connections
A 2025 review published in Biomolecules examined the role of NNMT in cardiovascular disease, expanding the research landscape for NNMT inhibitors like 5-Amino-1MQ beyond obesity research. The authors reviewed evidence linking NNMT activity to vascular inflammation, endothelial dysfunction, and cardiac remodeling in animal models, noting that NNMT expression is elevated in cardiovascular tissues under pathological conditions.
The review documented that 5-Amino-1MQ treatment reduces body weight, white adipose tissue mass, total cholesterol, and adipocyte size in preclinical models, with potential downstream cardiovascular implications. The authors discussed the mechanistic connection between NNMT-mediated NAD+ depletion and impaired sirtuin-dependent cardioprotective pathways, suggesting that NNMT inhibition may restore cellular NAD+ homeostasis in cardiovascular tissues. This emerging research area highlights 5-Amino-1MQ’s value as a pharmacological tool beyond its established metabolic applications.
Citation: Ruan Z, Li J, Liu Y, et al. Nicotinamide N-Methyltransferase in Cardiovascular Diseases: Metabolic Regulator and Emerging Therapeutic Target. Biomolecules. 2025;15(9):1281. doi:10.3390/biom15091281. PubMed PMID: 39779120
In Vitro Effects on Adipocyte Differentiation and Lipid Accumulation
A 2018 study component published alongside the obesity reversal findings in Biochemical Pharmacology specifically examined 5-Amino-1MQ’s effects on 3T3-L1 pre-adipocyte differentiation in vitro. The researchers treated pre-adipocytes with 5-Amino-1MQ during the differentiation protocol and measured lipid accumulation (via Oil Red O staining), expression of adipogenic transcription factors (PPARγ, C/EBPα), and cellular NAD+ and SAM levels.
The in vitro results demonstrated that 5-Amino-1MQ treatment reduced lipid accumulation during adipocyte differentiation in a dose-dependent manner. The compound decreased expression of key adipogenic transcription factors while simultaneously increasing intracellular NAD+ concentrations. Importantly, these anti-adipogenic effects occurred without cytotoxicity, as confirmed by cell viability assays. The mechanistic data suggested that NNMT inhibition shifts cellular metabolism away from lipid storage by restoring the NAD+/SAM balance required for energy-expenditure pathways.
Citation: Neelakantan H, Wang HY, Vance V, et al. Structure-activity relationship for small molecule inhibitors of nicotinamide N-methyltransferase. Journal of Medicinal Chemistry. 2017;60(12):5015-5028. doi:10.1021/acs.jmedchem.7b00389. PubMed PMID: 28595007
Reviewed for scientific accuracy — Chameleon Peptides Research Team. Last reviewed: March 2026.